Primerica
PRI NYSE Life & Health Insurance Financials FY2016βFY2025
Primerica's revenue rose 6.6% to $3.3 billion in fiscal 2025. Its net margin was 22.8%, up from 15.2% a year earlier. It paid out $586 million in dividends and buybacks. The diluted share count fell 4.4%.
About these figures. Debt is Primerica's notes payable, its senior notes; its 2021 filing tags them under another label. Primerica's cash flow statement doesn't show its spending on property and equipment as a line of its own, so capital spending and free cash flow are left blank.
What Primerica does
No business description yet.
- Legal name
- Primerica, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-082233
0001475922
Revenue and margins
Primerica had $3.3B of revenue in fiscal 2025, up 6.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 19.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Primerica returned $586M to shareholders in fiscal 2025. The diluted share count fell 4.4%.
Value Primerica yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $160M and divides by 32.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 11.0x Β· peers 14.4x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Primerica can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $478M | $559M | $594M | $688M | $756M |
| Debt incl. finance leases | $593M | $594M | $594M | $596M | $596M |
| Net debt / EBITDA | 0.2x | 0.0x | 0.0x | β0.1x | β0.2x |
| Debt / equity | 0.6x | 0.3x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 22.0x | 27.4x | 30.0x | 39.8x | 43.2x |
| Total assets | $16.2B | $14.6B | $15.0B | $14.6B | $15.0B |
| Total liabilities | $14.0B | $12.6B | $13.0B | $12.3B | $12.6B |
| Shareholders' equity | $925M | $2.0B | $2.1B | $2.3B | $2.4B |
| Net debt (β = net cash) | $115M | $35.1M | β$0.2M | β$92.3M | β$160M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$4.5M
5 insiders
Of sales under plans
93%
$4.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Peter W. SchneiderPresident | Sold plan | 1,800 | $312.65 | $0.6M | Form 4 |
| Aug 11, 2026 | Amber Lynne CottleDirector | Sold | 279 | $313.63 | $0.1M | Form 4 |
| Aug 10, 2026 | Glenn J. WilliamsChief Executive Officer, Director | Sold plan | 1,500 | $320.20 | $0.5M | Form 4 |
| Jun 12, 2026 | Glenn J. WilliamsChief Executive Officer, Director | Sold plan | 1,500 | $280.49 | $0.4M | Form 4 |
| May 18, 2026 | Peter W. SchneiderPresident | Sold plan | 1,800 | $279.64 | $0.5M | Form 4 |
| Mar 10, 2026 | Peter W. SchneiderPresident | Sold plan | 1,800 | $252.38 | $0.5M | Form 4 |
| Mar 2, 2026 | Nicholas Adam JendusaPrincipal Accounting Officer | Sold | 190 | $255.51 | $0.0M | Form 4 |
| Feb 17, 2026 | Glenn J. WilliamsChief Executive Officer, Director | Sold plan | 2,500 | $256.41 | $0.6M | Form 4 |
| Dec 3, 2025 | Joel M. BabbitDirector | Sold | 700 | $255.00 | $0.2M | Form 4 |
| Nov 17, 2025 | Peter W. SchneiderPresident | Sold plan | 2,000 | $255.30 | $0.5M | Form 4 |
| Nov 12, 2025 | Glenn J. WilliamsChief Executive Officer, Director | Sold plan | 2,500 | $259.65 | $0.6M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β0.8% | β2.6% | β1.0% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Primerica PRI | $8.6B | 6.6% | β | β | 34.5% | 11.0x | β | |
| CNO Financial Group CNO | $5.1B | 0.9% | 12.3% | β | β | 18.4x | β | Compare β |
| Globe Life GL | $12.2B | 3.7% | β | 20.9% | 16.0% | 10.3x | β | Compare β |
| Brighthouse Financial BHF | $2.6B | 43.2% | β | β | β | 3.6x | β | Compare β |
| Unum UNM | $14.4B | 1.5% | β | 4.3% | 7.6% | 21.0x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.5B | $1.7B | $1.9B | $2.1B | $2.2B | $2.7B | $2.7B | $2.7B | $3.1B | $3.3B |
| Gross profit | β | β | β | β | β | $2.7B | $2.6B | $2.7B | β | β |
| Interest expense | $28.7M | $28.5M | $28.8M | $28.8M | $28.8M | $30.6M | $27.2M | $26.6M | $24.2M | $23.1M |
| Pretax income | $338M | $380M | $416M | $477M | $507M | $644M | $719M | $772M | $939M | $975M |
| Income tax | $118M | $29.3M | $92.0M | $111M | $121M | $168M | $164M | $181M | $219M | $223M |
| Net income | $219M | $350M | $324M | $366M | $386M | $477M | $472M | $577M | $471M | $751M |
| Diluted EPS | $4.59 | $7.61 | $7.33 | $8.62 | $9.57 | $11.99 | $12.33 | $15.94 | $13.71 | $22.91 |
| Diluted shares | 0.05B | 0.05B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $294M | $392M | $478M | $486M | $643M | $657M | $758M | $693M | $862M | $901M |
| Depreciation and amortization | $14.6M | $13.6M | $12.4M | $18.3M | $17.7M | $29.8M | $34.2M | $32.0M | $23.4M | $19.3M |
| Stock-based compensation | $13.4M | $15.3M | $17.3M | $17.5M | $19.0M | $16.8M | $22.4M | $18.9M | $25.1M | $24.6M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $495M | $3.9M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $150M | $150M | $210M | $225M | $231M | $18.8M | $356M | $375M | $425M | $450M |
| Dividends paid | $33.4M | $35.8M | $44.1M | $57.6M | $64.3M | $74.6M | $83.8M | $93.7M | $113M | $136M |
| Dividends and buybacks | $183M | $186M | $254M | $283M | $296M | $93.4M | $440M | $469M | $538M | $586M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $212M | $280M | $270M | $257M | $548M | $478M | $559M | $594M | $688M | $756M |
| Total debt | $373M | $373M | $374M | $374M | $374M | $592M | $593M | $594M | $595M | $595M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.7M | $0.9M | $1.0M | $0.8M | $0.5M | $1.0M | $1.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $27.5M | $28.1M | $36.0M | $46.1M | $57.7M | $67.0M | $52.7M | $37.6M | $40.7M | $39.8M |
| Total assets | $11.4B | $12.5B | $12.6B | $13.7B | $14.9B | $16.2B | $14.6B | $15.0B | $14.6B | $15.0B |
| Total liabilities | $10.2B | $11.0B | $11.1B | $12.0B | $13.1B | $14.0B | $12.6B | $13.0B | $12.3B | $12.6B |
| Shareholders' equity | $1.2B | $1.4B | $1.5B | $1.7B | $1.8B | $925M | $2.0B | $2.1B | $2.3B | $2.4B |
| Margins | ||||||||||
| Gross margin | β | β | β | β | β | 98.1% | 97.4% | 98.0% | β | β |
| EBITDA margin | 25.1% | 25.0% | 24.1% | 25.5% | 25.0% | 26.0% | 29.4% | 30.2% | 32.0% | 30.9% |
| Net margin | 14.4% | 20.7% | 17.1% | 17.9% | 17.4% | 17.6% | 17.8% | 21.0% | 15.2% | 22.8% |
| Returns | ||||||||||
| Return on capital | 17.3% | 26.0% | 22.5% | 23.3% | 23.8% | β | 37.1% | 29.6% | 34.9% | 34.5% |
| Return on equity | 18.5% | 26.5% | 22.5% | 23.5% | 22.1% | 34.6% | 31.9% | 28.2% | 21.8% | 31.9% |
| Return on assets | 2.0% | 2.9% | 2.6% | 2.8% | 2.7% | 3.1% | 3.1% | 3.9% | 3.2% | 5.1% |
| Growth | ||||||||||
| Revenue growth | 8.2% | 11.2% | 12.5% | 8.0% | 8.0% | 22.2% | β1.9% | 3.4% | 12.4% | 6.6% |
| Net income growth | 15.6% | 59.6% | β7.5% | 13.1% | 5.4% | 23.6% | β1.1% | 22.1% | β18.4% | 59.7% |
| EPS growth | 24.1% | 65.8% | β3.7% | 17.6% | 11.0% | 25.3% | 2.8% | 29.3% | β14.0% | 67.1% |
| Share count change | β6.8% | β3.7% | β3.7% | β3.8% | β5.0% | β1.3% | β3.9% | β5.5% | β5.1% | β4.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.4x | 0.2x | 0.2x | 0.2x | β0.3x | 0.2x | 0.0x | 0.0x | β0.1x | β0.2x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.2x | 0.2x | 0.6x | 0.3x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 12.8x | 14.3x | 15.4x | 17.6x | 18.6x | 22.0x | 27.4x | 30.0x | 39.8x | 43.2x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.9% | 0.9% | 0.9% | 0.9% | 0.9% | 0.6% | 0.8% | 0.7% | 0.8% | 0.8% |
| Quality scores | ||||||||||
| Accruals ratio | β0.7% | β0.4% | β1.2% | β0.9% | β1.8% | β1.2% | β1.9% | β0.8% | β2.6% | β1.0% |
Source: SEC EDGAR XBRL filings (CIK 0001475922). Data updated October 11, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.